2016_Head & Neck COURSE BOOK

THERAPEUTIC OPTIONS OPEN QUESTIONS

FACTORS, OTHER THAN RT DOSE, INCLUDING HPV STATUS, MAY ULTIMATELY DICTATE LOCOREGIONAL RECURRENCE RISK IN PATIENTS WITH HEAD NECK CANCER OF UNKNOWN PRIMARY PATTERNS OF FAILURE AFTER RT

CONTRALATERAL NECK FAILURE IS RARE

Lee N. et al., Head Neck, 2015

Galloway TJ et al, J Clin Oncol, 2015

SYSTEMIC THERAPY

INTENSIFICATION OF (LOCO)REGIONAL TREATMENT: IMPROVING NECK CONTROL PALLIATE THE SYMPTOMS OF REGIONALLY ADVANCED DISEASE OR SYSTEMIC METASTASES

IMPACT OF IMMUNOTHERAPY WAS NOT DESCRIBED IN LITERATURE

Nieder C et al., J Radiat Oncol Biol Phys, 2001 Jereczek-Fossa BA et al., Cancer Treat Rev 2004 Strojan P et al., Head Neck 2013 P Shumann, J Cranio Max Fac Surg 2015

mercoledì 29 giugno 16